Sonoma Pharmaceuticals, Inc. (SNOA) Amy Trombly, CEO

The Wall Street Resource

Sonoma Pharmaceuticals

is a global healthcare leader for developing and producing stabilized

hypochlorous acid (HOCl) products for a wide range of applications, including

wound care, eye care, nasal care, oral care, dermatological conditions, animal

health care and non-toxic disinfectants. The company's products reduce

infections, itch, pain, scarring and harmful inflammatory responses in a safe

and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl)

show it to have impressive antipruritic, antimicrobial, antiviral and

anti-inflammatory properties. Sonoma's stabilized HOCl immediately relieves

itch and pain, kills pathogens and breaks down biofilm, does not sting or

irritate skin, and oxygenates the cells in the area treated, assisting the body

in its natural healing process. The company's products are sold either directly

or via partners in 55 countries worldwide.